Search concepts
|
Selected Filters
|
- 650 - 700 out of 1,428 results
Search results
-
Prevention of De Novo HCV with Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant
9/18/18 → 9/17/43
Project: Non Profit
-
Effects of epidural and transcutaneous spinal stimulation
Sayenko, D., Barber, S., Britz, G. W., Horner, P. J., Kaldis, T., Karmonik, C. & Villapol, S.
9/27/18 → …
Project: Clinical Trial
-
The role of the gut microbiome in the neuropathology of traumatic brain injury
Villapol, S. & Kumaraswami, M.
10/1/18 → 3/31/22
Project: Federal Funding Agencies
-
-
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
11/8/18 → 8/31/22
Project: Federal Funding Agencies
-
Evaluation of Pre-transplant T Cell Exhaustion as a Mechanism for Recipient Immune Dysfunction and Liver Transplant Futility
11/15/18 → 11/30/19
Project: Non Profit
-
Study of Lamborghini's carbon fiber composites for aerospace applications
11/26/18 → 10/30/22
Project: Federal Funding Agencies
-
-
Therapeutic Ventral Spinal Stimulation for Motor Plasticity and Repair after Spinal Cord Injury
12/1/18 → 11/30/19
Project: Non Profit
-
A Multi-Center, Randomized, Placebo Controlled, Double-Blinded, Trial of Efficacy and Safety of Riluzole in Acute Spinal Cord Injury
1/1/19 → 12/31/19
Project: Non Profit
-
Role of MIF in myeloma bone homing and drug response
1/1/19 → 12/31/22
Project: Federal Funding Agencies
-
-
-
Genetic mechanism of conserved ancestral haplotype in SCA10
2/1/19 → 6/30/24
Project: Federal Funding Agencies
-
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Abraham, B. P., Fan, C. & Glassner, K.
2/11/19 → …
Project: Clinical Trial
-
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2/13/19 → …
Project: Clinical Trial
-
Determinants of Streptococcus pyogenes virulence in the primate oropharynx: A genome-wide analysis
2/15/19 → 1/31/22
Project: Federal Funding Agencies
-
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2/19/19 → …
Project: Clinical Trial
-
Resubmission_R01_Subcontract_MD Anderson-Early Detection of Hepatocellular Carcinoma
2/19/19 → …
Project: Clinical Trial
-
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non¿Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature
Bernicker, E. H., Darcourt, J. & Zhang, J.
2/28/19 → 2/27/44
Project: Non Profit
-
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
3/1/19 → 2/28/23
Project: Federal Funding Agencies
-
NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Geyer, C. E., Chang, J. C., Darcourt, J. & Niravath, P. A.
3/12/19 → 2/28/25
Project: Non Profit
-
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)
Chiu, D., Gadhia, R. R., Garg, T., Misra, V. & Volpi, J. J.
3/14/19 → …
Project: Clinical Trial
-
-
A Multicenter, Registry Study of Avance® Nerve Graft Utilization, Evaluations and Outcomes in Peripheral Nerve Injury Repair
3/21/19 → …
Project: Clinical Trial
-
Higher Neural Contribution Underlying Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia Undergoing Bladder Outlet Procedures.
4/1/19 → 7/31/22
Project: Federal Funding Agencies
-
Polycystin-1-dependent governance of cardiomyocyte hypertrophy via potassium channel control
4/1/19 → 3/31/23
Project: Non Profit
-
CRISPR-nanoparticle for macrophage reprogramming: New therapeutic strategy for breast cancer liver metastasis
4/1/19 → 3/10/21
Project: Non Profit
-
Central Effects of Task-Specific Spinal Neuromodulation in Individuals with Spinal Cord Injury
4/3/19 → 4/2/20
Project: Non Profit
-
Defining Immunology Frailty as a Predictor of Human Liver Allograft Recipient Futility
Chen, W., Eagar, T. N., Ghobrial, R. M., Graviss, E. A., Gupte, A. A., Hamilton, D. J. & Li, X. C.
4/10/19 → 8/31/19
Project: Federal Funding Agencies
-
-
Daratumab to Enhance therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
4/30/19 → 4/29/29
Project: Non Profit
-
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
5/1/19 → 4/30/24
Project: Federal Funding Agencies
-
Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli
Valderrábano, M. & Fung, S. H.
5/1/19 → 11/1/23
Project: Federal Funding Agencies
-
-
Study of responses to CD44 targeted nanovectors to design a novel adjunctive anti-tuberculosis host-directed therapy
5/15/19 → 3/28/20
Project: Federal Funding Agencies
-
Disrupting Six/Eya signalling as new therapy for lung fibrosis
5/15/19 → 11/14/21
Project: Federal Funding Agencies
-
Neuromuscular Observational Research (MOVR) Data Hub Protocol
Greene, E. P., Appel, S. H., Shroff, S. & Thonhoff, J. R.
5/17/19 → …
Project: Clinical Trial
-
Longitudinal study of wound microbiomes in healing and non-healing dehisced wounds
Oviedo, R. J.
6/1/19 → 9/23/23
Project: Non Profit
-
Novel Therapeutic Strategies to Co-Target AR+ and AR-/lo Prostate Cancer Cells
6/1/19 → 5/31/24
Project: Federal Funding Agencies
-
Determinants of Streptococcus pyogenes fitness in the female primate genital tract: A genome-wide analysis
6/1/19 → 5/31/22
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
6/1/19 → 4/30/24
Project: Federal Funding Agencies
-
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Ibrahim, H. N.
6/1/19 → 5/31/20
Project: Federal Funding Agencies
-
Mitochondrial transplantation: a novel therapy for lung fibrosis
6/1/19 → 11/30/22
Project: Federal Funding Agencies
-
A Neonatal Monkey Model of Tuberculosis Vaccination
6/1/19 → 5/31/23
Project: Federal Funding Agencies